Low levels of STAT5 have been previously associated with poor prognosis [39] and with high grade cancers [40], on the contrary, high STAT5 expression has been associated with well differentiated adenocarcinomas and with better prognosis [41,42,43]. The gene discussed is STAT5A; the disease is adenocarcinoma.